Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
BMC Infect Dis ; 20(1): 687, 2020 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-32948147

RESUMEN

BACKGROUND: Vogesella species are common aquatic, Gram-negative rod-shaped bacteria, originally described in 1997. Vogesella perlucida was first isolated from spring water in 2008. Furthermore, bacterial pathogenicity of Vogesella perlucida has never been reported. Here, we report the first case of rare Vogesella perlucida-induced bacteremia in an advanced-age patient with many basic diseases and history of dexamethasone abuse. CASE PRESENTATION: A 71-year-old female was admitted with inflamed upper and lower limbs, rubefaction, pain and fever (about 40 °C). She had been injured in a fall at a vegetable market and then touched river snails with her injury hands. A few days later, soft tissue infection of the patient developed and worsened. Non-pigmented colonies were isolated from blood cultures of the patient. Initially, Vogesella perlucida was wrongly identified as Sphingomonas paucimobilis by Vitek-2 system with GN card. Besides, we failed to obtain an acceptable identification by the MALDI-TOF analysis. Finally, the isolated strain was identified as Vogesella perlucida by 16S rRNA gene sequences. In addition, the patient recovered well after a continuous treatment of levofloxacin for 12 days. CONCLUSION: Traditional microbiological testing system may be inadequate in the diagnosis of rare pathogenic bacteria. Applications of molecular diagnostics techniques have great advantages in clinical microbiology laboratory. By using 16S rRNA gene sequence analysis, we report the the first case of rare Vogesella perlucida-induced bacteremia.


Asunto(s)
Bacteriemia/microbiología , Betaproteobacteria/patogenicidad , Infecciones de los Tejidos Blandos/microbiología , Anciano , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Técnicas de Tipificación Bacteriana , Betaproteobacteria/clasificación , Betaproteobacteria/genética , Betaproteobacteria/aislamiento & purificación , Femenino , Humanos , Levofloxacino/uso terapéutico , ARN Ribosómico 16S/genética , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Vancomicina/uso terapéutico
2.
BMC Infect Dis ; 20(1): 709, 2020 Sep 29.
Artículo en Inglés | MEDLINE | ID: mdl-32993557

RESUMEN

An amendment to this paper has been published and can be accessed via the original article.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA